Complement and kidney disease, new insights

Nicholas R Medjeral-Thomas1, Matthew C Pickering, H Terence Cook

  • 1Department of Immunology and Inflammation, Faculty of Medicine, Imperial College London, UK.

Insights

The complement pathway is crucial in kidney diseases like C3 glomerulopathy and IgA nephropathy. Targeting complement activation offers potential therapeutic strategies for these conditions.

Area of Science:

  • Nephrology
  • Immunology
  • Molecular Medicine

Background:

  • The complement system, a key part of innate immunity, plays an increasingly recognized role in the pathogenesis of various kidney diseases.
  • Dysregulation of complement activation is implicated in conditions such as C3 glomerulopathy (C3G), IgA nephropathy (IgAN), and thrombotic microangiopathy.

Purpose of the Study:

  • To review recent studies highlighting the significance of the complement pathway in kidney disease.
  • To discuss the pathogenic insights and therapeutic potential derived from understanding complement's role.

Main Methods:

  • Review of recent scientific literature focusing on complement activation in kidney diseases.
  • Analysis of immunohistochemical findings, genetic associations, and clinical data in C3G and IgAN.
  • Examination of therapeutic studies involving complement inhibitors.

Main Results:

  • In C3G, factor H related protein 5 (FHR5) deposition correlates with kidney function, and mycophenolate mofetil (MMF) shows therapeutic promise.
  • In IgAN, imbalances in factor H (FH) and FHR proteins (FHR1, FHR5) are associated with disease severity, alongside contributions from the lectin complement pathway.
  • Complement activation is evident across diverse kidney diseases, indicating its broad pathogenic relevance.

Conclusions:

  • The complement pathway is a critical factor in the development and progression of multiple kidney diseases.
  • Understanding complement dysregulation provides valuable pathogenic insights and identifies targets for novel therapies.
  • Ongoing drug development targeting complement activation holds significant therapeutic potential for kidney disease patients.
Abstract

Related Concept Videos

Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
508
Complement System01:27

Complement System

The complement system is a group of approximately 20 plasma proteins that strengthen the body's defenses against infections through opsonization, inflammation, and cell lysis. Opsonization involves coating pathogens with complement proteins, making them more recognizable and facilitating phagocyte engulfment. Certain complement proteins induce inflammation that attracts immune cells to the site of infection. Cell lysis involves the destruction of pathogens through the formation of a...
6.2K
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
127
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
273
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
340
Renal Corpuscle01:20

Renal Corpuscle

The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
5.2K